Clinical Trials
3 trialsNCT03114527 2026-05-22
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
Fox Chase Cancer Center
Phase 2 Active not recruiting
NCT03096912 2017-10-25
A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT02571829 2016-11-23
A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Hadassah Medical Organization
Phase 2 Unknown